From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “narcolepsy type 1” 60

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Diagnostic value of nocturnal sleep-onset rapid eye movement sleep period for narcolepsy type 1 and 2 in a tertiary sleep centre
2025 Sleep Medicine article Neuroscience Sleep and Wakefulness Research Open access

Veronique E C Vael, Denise Bijlenga, Anne A van der Wel, Izabelle Koers, Rolf Fronczek, Gert Jan Lammers

0

citations
Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Yves A Dauvilliers, RR Grunstein, Emmanuel Mignot, G.J. Lammers, DT Plante, Erik Buntinx, +7 more

0

citations
Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
2026 New England Journal of Medicine article Neuroscience Sleep and Wakefulness Research Open access

Yves A Dauvilliers, Emmanuel Mignot, Jakub Antczak, Isabelle Arnulf, Lucie Barateau, Erik Buntinx, +32 more

3

citations
MRI ‐based surrogates of brain clearance in narcolepsy type 1
2025 Journal of Sleep Research article Neuroscience Sleep and Wakefulness Research Open access

Eva M. van Heese, Jari K. Gool, Gert Jan Lammers, Ysbrand D. van der Werf, Matthias J.P. van Osch, Rolf Fronczek, +1 more

5

citations
The Sustained Attention to Response Task Shows Lower Cingulo-Opercular and Frontoparietal Activity in People with Narcolepsy Type 1: An fMRI Study on the Neural Regulation of Attention
2020 Brain Sciences article Neuroscience Sleep and Wakefulness Research Open access

Jari K. Gool, Ysbrand D. van der Werf, Gert Jan Lammers, Rolf Fronczek

13

citations
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
2025 New England Journal of Medicine article Neuroscience Sleep and Wakefulness Research Open access

Yves A Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot, Gert Jan Lammers, Rafael del Río Villegas, Ramin Khatami, +13 more

62

citations
Role of Brown Adipose Tissue in Adiposity Associated With Narcolepsy Type 1
2020 Frontiers in Endocrinology article Neuroscience Sleep and Wakefulness Research Open access

Maaike E. Straat, Mink Sebastian Schinkelshoek, Rolf Fronczek, Gert Jan Lammers, Patrick C.N. Rensen, Mariëtte R. Boon

22

citations
Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1
2022 SLEEP article Neuroscience Sleep and Wakefulness Research Open access

Adrienne Elisabeth van der Hoeven, Rolf Fronczek, Mink Sebastian Schinkelshoek, Freek W. C. Roelandse, Jaap Adriaan Bakker, Sebastiaan Overeem, +2 more

34

citations
0724 Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton in Patients with Narcolepsy Type 1: The Phase 2 Vibrance-1 Study
2026 SLEEP article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Ron Grunstein, Emmanuel Mignot, Gert Jan Lammers, David Plante, Erik Buntinx, +7 more

0

citations
Enhanced Visual Cortex Activation in People With Narcolepsy Type 1 During Active Sleep Resistance: An fMRI-EEG Study
2022 Frontiers in Neuroscience article Neuroscience Sleep and Wakefulness Research Open access

Jari K. Gool, Rolf Fronczek, Johan N. van der Meer, Ysbrand D. van der Werf, Gert Jan Lammers

2

citations
Effects of Oveporexton, an Orexin Receptor 2–Selective Agonist, on Cognition in Narcolepsy Type 1
2025 JAMA Neurology article Neuroscience Sleep and Wakefulness Research Open access

Gert Jan Lammers, Giuseppe Plazzi, Emmanuel Mignot, Fabio Pizza, Yves A Dauvilliers, Lucie Barateau, +9 more

12

citations
Increased Numbers of CD4 + T‐Cells in the Hypocretin/Orexin Region of Narcolepsy Type 1
2026 Annals of Neurology article Neuroscience Sleep and Wakefulness Research Open access

Ling Shan, Milo Fonville, Mabel Hoekstra, Rolf Fronczek, Joost Smolders, Dick Frans Swaab

5

citations
Narcolepsy Type 1: Should We Only Target Hypocretin Receptor 2?
2023 Clinical and Translational Neuroscience article Neuroscience Sleep and Wakefulness Research Open access

Rolf Fronczek, Gert Jan Lammers

3

citations
Reduced Numbers of Corticotropin‐Releasing Hormone Neurons in Narcolepsy Type 1
2022 Annals of Neurology article Neuroscience Sleep and Wakefulness Research Open access

Ling Shan, Rawien A. Balesar, Dick Frans Swaab, Gert Jan Lammers, Rolf Fronczek

44

citations
Activated Wake Systems in Narcolepsy Type 1
2023 Annals of Neurology article Neuroscience Sleep and Wakefulness Research Open access

Ling Shan, Suzan Linssen, Zoe Harteman, Fleur den Dekker, Lamis Shuker, Rawien A. Balesar, +6 more

18

citations
Recent insights into the pathophysiology of narcolepsy type 1
2024 Sleep Medicine Reviews article Neuroscience Sleep and Wakefulness Research Open access

Marieke Vringer, Jingru Zhou, Jari K. Gool, Denise Bijlenga, Gert Jan Lammers, Rolf Fronczek, +1 more

13

citations
Physiological and psychological stress reactivity in narcolepsy type 1
2024 SLEEP article Neuroscience Sleep and Wakefulness Research Open access

Marieke Vringer, Denise Bijlenga, Jingru Zhou, Onno Cornelis Meijer, Christiaan H. Vinkers, Gert Jan Lammers, +1 more

4

citations
HLA associations in narcolepsy type 1 persist after the 2009 H1N1 pandemic
2020 Journal of Neuroimmunology article Neuroscience Sleep and Wakefulness Research Open access

Mink Sebastian Schinkelshoek, Rolf Fronczek, Willem Verduijn, Geert W. Haasnoot, Sebastiaan Overeem, Claire E. H. M. Donjacour, +4 more

3

citations
Efficacy and Safety of TAK-861, an Oral Orexin Receptor 2 Agonist, in Individuals with Narcolepsy Type 1: Results from a Phase 2 Trial and Long-Term Extension Study Interim Analysis (P12-4.002)
2025 Neurology article Neuroscience Sleep and Wakefulness Research

Yves A Dauvilliers, Emmanuel Mignot, Giuseppe Plazzi, Gert Jan Lammers, Harisha Kadali, Ellie Stukalin, +6 more

1

citations
Conventional autoantibodies against brain antigens are not routinely detectable in serum and CSF of narcolepsy type 1 and 2 patients
2020 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Anelia Dietmann, Michael Peter Horn, Mink Sebastian Schinkelshoek, Rolf Fronczek, Anke Salmen, Panagiotis Bargiotas, +3 more

6

citations
Narcolepsy type 1 and Sydenham chorea – Report of 3 cases and review of the literature
2023 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Elena Wenz, Mink Sebastian Schinkelshoek, Ulf Kallweit, Rolf Fronczek, Rana Rezaei, Ramin Khatami, +2 more

6

citations
The First Light: Efficacy and Safety of a Multi-Dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Emmanuel Mignot, Isabelle Arnulf, Giuseppe Plazzi, Rafael del Río Villegas, R. Khatami, G.J. Lammers, +9 more

2

citations
Characterization of the nature, severity, and subjective experience of Cognitive Symptoms Associated with Narcolepsy Type 1
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

G.J. Lammers, P. Maruff, T. Banerjee, Robert H. Pietrzak, H. Romero, Ellie Stukalin, +2 more

1

citations
Improvement in Patient-reported Cognitive Functioning in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Yves A Dauvilliers, RR Grunstein, Emmanuel Mignot, G.J. Lammers, DT Plante, +7 more

0

citations
Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Yves A Dauvilliers, RR Grunstein, Emmanuel Mignot, G.J. Lammers, DT Plante, +6 more

0

citations